Towards Cure Via Only Ultra-short ICB in CSCC

NCT06823479 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Squamous Cell Carcinoma (CSCC)
Cutaneous Squamous Cell Cancer
Cutaneous Squamous Cell Carcinoma of the Head and Neck
Cutaneous Squamous Cell Carcinoma

Interventions

DRUG: Nivolumab
DRUG: Ipilumimab

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]